Greenwich LifeSciences Inc

NAS:GLSIHealthcareCBOEFTSE:MRUTNASDAQ:NQUSSG

$15.21+4.54%At closeAt close · Tue 20 Oct · ≈ AED 55.86 · Market cap $223.26M · Next earnings Fri 13 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Return on equity	−6.7%	−17.0%	−59.2%	−132.7%	−687.2%	−5,480.5%	−5,480.5%	+0.0 pts
Return on assets	−6.5%	−16.8%	−58.1%	−127.1%	−425.4%	−313.3%	−313.3%	+0.0 pts
Return on capital employed	−6.7%	−17.1%	−60.8%	−139.2%	−696.0%	−5,505.9%	—	—
Debt / equity	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—
Debt / assets	1.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—
Interest coverage	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Current ratio	27.4×	70.6×	51.2×	23.7×	2.6×	1.1×	1.1×	+0.0%
Quick ratio	27.4×	70.6×	51.2×	23.7×	2.6×	1.1×	—	—
Cash ratio	27.4×	70.6×	51.2×	23.7×	2.6×	1.1×	1.1×	+0.0%
Asset turnover	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.